Abstract-We explored the effects of direct renal interstitial stimulation of dopamine D 1 -like receptors with fenoldopam, a selective D 1 -like receptor agonist, on renal sodium excretion and angiotensin type-2 (AT 2 ) receptor expression and cellular distribution in rats on a high-sodium intake. In contrast to vehicle-infused rats, sodium excretion increased in fenoldopam-infused rats during each of three 1-hour experimental periods (Ͻ0.001 Key Words: angiotensin Ⅲ dopamine Ⅲ receptors Ⅲ sodium excretion Ⅲ natriuresis Ⅲ receptor trafficking Ⅲ kidney T he kidney is endowed with 2 local hormonal systems that play a major role in the regulation of sodium (Na ϩ ) transport across the renal proximal tubule (RPT): the reninangiotensin system and the dopaminergic system. In vitro studies show that angiotensin II (Ang II), the major effector peptide of the renin-angiotensin system, acts at angiotensin type-1 (AT 1 ) receptors on RPT cell membranes to increase Na ϩ transport across the cell from the lumen into the interstitial space and peritubular capillaries by stimulating Na ϩ -hydrogen (H ϩ ) exchanger-3 (NHE-3) and Na ϩ ,K ϩ -ATPase activities, respectively. 1 On the other hand, dopamine (DA), synthesized in and secreted from RPT cells, activates D 1 -like receptors (D 1 and D 5 receptor subtypes) on RPT cells to inhibit Na ϩ reabsorption by inhibiting NHE-3 and Na ϩ ,K ϩ -ATPase activities. 2,3 Although these 2 hormonal systems act in opposite directions on RPT Na ϩ transport in vitro, little is known regarding the physiological interactions of intrarenal Ang II and DA in the control of Na ϩ excretion in vivo. Approximately 50% of basal Na ϩ excretion is mediated by the paracrine action of renal DA on RPT D 1 -like receptors. 4, 5 However, the mechanisms of receptor interaction that govern DA-induced natriuresis are incompletely understood. DA downregulates AT 1 receptors (AT 1 Rs) in the RPT. 6 However, Ang II binds to angiotensin type-2 (AT 2 ) receptors (AT 2 Rs), as well as AT 1 Rs, and the effects of DA on AT 2 Rs are unknown.
T he kidney is endowed with 2 local hormonal systems that play a major role in the regulation of sodium (Na ϩ ) transport across the renal proximal tubule (RPT): the reninangiotensin system and the dopaminergic system. In vitro studies show that angiotensin II (Ang II), the major effector peptide of the renin-angiotensin system, acts at angiotensin type-1 (AT 1 ) receptors on RPT cell membranes to increase Na ϩ transport across the cell from the lumen into the interstitial space and peritubular capillaries by stimulating Na ϩ -hydrogen (H ϩ ) exchanger-3 (NHE-3) and Na ϩ ,K ϩ -ATPase activities, respectively. 1 On the other hand, dopamine (DA), synthesized in and secreted from RPT cells, activates D 1 -like receptors (D 1 and D 5 receptor subtypes) on RPT cells to inhibit Na ϩ reabsorption by inhibiting NHE-3 and Na ϩ ,K ϩ -ATPase activities. 2, 3 Although these 2 hormonal systems act in opposite directions on RPT Na ϩ transport in vitro, little is known regarding the physiological interactions of intrarenal Ang II and DA in the control of Na ϩ excretion in vivo. Approximately 50% of basal Na ϩ excretion is mediated by the paracrine action of renal DA on RPT D 1 -like receptors. 4, 5 However, the mechanisms of receptor interaction that govern DA-induced natriuresis are incompletely understood. DA downregulates AT 1 receptors (AT 1 Rs) in the RPT. 6 However, Ang II binds to angiotensin type-2 (AT 2 ) receptors (AT 2 Rs), as well as AT 1 Rs, and the effects of DA on AT 2 Rs are unknown.
AT 2 Rs are expressed in the RPT but have a low degree of renal expression compared with that of AT 1 Rs. 7 The present study explores the direct renal interstitial (RI) stimulation of D 1 receptors with fenoldopam, a selective D 1 -like receptor agonist, and its effects on renal Na ϩ excretion and AT 2 R expression in the rat. We demonstrate that natriuresis induced by stimulation of renal D 1 -like receptors requires AT 2 R expression and recruitment to the RPT plasma membrane. In the presence of AT 2 R inhibition, D 1 -like receptor stimulation is not able to induce renal Na ϩ excretion.
Methods

Animal Preparation
The experimental protocols, approved by the University of Virginia Animal Care and Use Committee, were conducted on 250-g Sprague-Dawley rats obtained from Harlan Teklad and were housed in the University of Virginia School of Medicine vivarium (temperature: 21Ϯ1°C; humidity: 60Ϯ10%; and light: 8:00 AM to 8:00 PM). For 1 week before and during the experiments the rats were maintained on a standard high Na ϩ rat chow containing 4% NaCl. On day 7, the rats were placed in metabolic cages, and 24-hour urine samples were collected and assayed for Na ϩ excretion (U Na V). Representative U Na V was 7.12 mol/min (normal: 1 mol/min).
The rats were anesthetized with Nembutal (0.3 mL IP), and a tracheostomy was performed. Arterial access for BP monitoring was achieved by direct cannulation of the right carotid artery. For hydration with 5% dextrose in water at 20 L/min, cannulation of the left jugular vein was performed. The right kidney was excised, and a microcatheter (PE-10) was inserted into the ureter of the remaining (left) kidney for urine collection.
Renal Cortical Interstitial Infusion
One or 2 microcatheters (PE-10), depending on the study, were inserted into the cortical interstitial space of the left kidney for direct RI infusion of pharmacological agents (see protocols) or vehicle at an infusion rate of 2.5 L/min. The infusion catheters were connected to a Harvard pump 5522. On completion of the study, the left kidney was carefully excised and the rat euthanized.
RI Microdialysis
Renal cortical interstitial microdialysis for RI fluid Ang II was conducted according to methods used in past studies. 8, 9 Ang II Assay RI Ang II was measured by enzyme immunoassay kit (Cayman Chemical). The assay sensitivity is 1 pg/mL. The assay has 4% cross-reactivity with Ang I and 36% cross-reactivity with desaspartyl 1 -Ang II (Ang III). Relative recovery is 90% for Ang II in our microdialysis system. 10 
Blood Pressure Measurements
Mean arterial blood pressure was monitored by a carotid artery catheter via a digital blood pressure analyzer (Micromed Inc). Mean arterial blood pressure values were recorded every 5 minutes and averaged for each of the control and experimental periods.
Urine Collection and Analysis
Urine was collected from each rat hourly for 4 hours after a 1-hour equilibrium period and urinary flow rate (V) was calculated as microliters per minute. All of the collected urine was stored at 4°C. U Na V (microliters per minute) was quantified by a flame photometer (IL-943, Instrumentation Laboratory).
Membrane Preparation and Western Blot Analysis
Plasma membranes of both renal cortical and RPT cells were isolated by the method of Nagamatsu et al 11 with slight modifications. RPT cells were isolated by the method of Hawksworth. 12 The rat kidneys were minced and homogenized and membranes isolated by methods described above. The membranes were solubilized, and the protein concentration was determined by the bicinchoninic acid kit (Pierce). Sodium dodecylsulfate samples were prepared, separated by SDS-PAGE, and transferred onto a nitrocellulose membrane by electroblotting as reported previously. 13, 14 Ten micrograms of protein were loaded per lane. Protein loading and equal transfer of proteins to the membrane were verified by Ponceau S staining. The membrane was incubated with a rabbit AT 2 R polyclonal affinity-purified antibody at a concentration of 0.15 mg/mL (1:100 dilution) raised against a synthetic peptide sequence (MKDNFSFAATSRNITSS) derived from the amino-terminal extracellular tail of the rat AT 2 R amino acid sequence. This sequence was selected because of its uniqueness to the AT 2 R, with absence of significant homology to any other known protein. 13, 14 Blots were washed and incubated with peroxidaseconjugated donkey anti-rabbit secondary antibody for 2 hours. Immunoreactivity was visualized with enhanced chemiluminescence plus Western blotting detection kit (Amersham). Quantitative assessment of band densities was performed by scanning densitometry (ImageQuant, Molecular Dynamics). D 1 Rs were detected with D 1 408 antibody (a kind gift from Dr Pedro Jose) using a 1:1000 dilution. Western blotting was performed as described previously. 15 Blots were probed with donkey anti-rabbit secondary antibody.
RPT Apical Membrane Isolation
Apical membranes of RPT cells were isolated by first lysing the cells in detergent-free lysis buffer and performing a biotinylated lectin pull-down assay as follows. After the tissue was homogenized, 1 mg of total protein was incubated with 20 g of biotinylated Lotus tetragonolobus agglutinin (LTA) lectin (Vector Laboratories) in 10-mL volume for 2 hours at room temperature. A 50% vol/vol slurry (40 L) of Ultralink Neutravidin beads (Pierce Laboratory) was then added and incubated for 30 minutes. The beads were then pelleted and thoroughly washed 5 times using a microcentrifuge spin cup filter. The LTA affinity attached membranes were eluted by incubating the beads in the spin cup filter with 40 L of 50°C loading buffer and 20 L loaded per lane on a gel for Western blotting.
Protocols
Effects of Direct RI D 1 -Like Receptor Stimulation on U Na V and Renal D 1 R and AT 2 R
In this study, we evaluated the effects of direct RI infusion of fenoldopam on renal Na ϩ and water excretion in vivo and D 1 R and AT 2 R protein expression in both whole cells and plasma membranes of renal cortical and RPT cells in vitro. We hypothesized that intrarenal D 1 -like receptor stimulation would increase V, U Na V, whole cell AT 2 R expression, and AT 2 R recruitment to the plasma membranes of RPT cells of Na ϩ -loaded rats. Uninephrectomized control rats received a RI infusion of 5% dextrose in water vehicle at 2.5 L/min for the entire 4-hour study. The experimental rats were infused with vehicle for 1 hour and then received fenoldopam, a highly selective D 1 -like receptor agonist, at 1 g/kg per minute for the remaining 3 hours.
Effects of Intrarenal AT 2 R Blockade on D 1 -Like Receptor-Induced Natriuresis
In this study, we explored the ability of intrarenal AT 2 R antagonism to influence D 1 -like receptor-induced natriuresis. Our hypothesis was that pharmacological AT 2 R blockade would inhibit D 1 -like receptor-induced natriuresis. The RI space of control rats was infused with vehicle. The experimental rat kidneys were infused either with fenoldopam 1 g/kg per minute alone or fenoldopam plus PD-123319 (PD), a specific AT 2 R antagonist, at 2 g/kg per minute. The PD infusion was initiated at the beginning of the control period and continued for the entire 4-hour experiment, and fenoldopam was infused from hour 2 through hour 4 of the experiment.
Effects of D 1 -Like Receptor Blockade on Intrarenal D 1 -Like Receptor-Induced Natriuresis
This study was designed to demonstrate that fenoldopam-induced natriuresis is because of specific renal D 1 -like receptor activation. The control rats were similarly infused with vehicle. However, the experimental rats received an RI infusion of SCH-23390, a selective D 1 -like receptor antagonist, at 10 g/kg per minute, for the entire 4 hours. After a 1-hour control period, rat kidneys simultaneously received an RI infusion of fenoldopam at 1 g/kg per minute.
Effects of High Na
؉ Diet on Intrarenal Ang II Levels and AT 2 
R Expression
In this study, we determined whether high Na ϩ intake would suppress intrarenal Ang II levels in either RI fluid or cortical tissue and/or influence AT 2 R expression. Rats (Nϭ6 per group) were studied after 1 week on a normal (0.28%) or high (4%) NaCl diet. An interstitial microdialysis catheter was inserted into 1 kidney (subcapsular renal cortex) with animals under anesthesia, and RI fluid was collected for 60 minutes. The animals were euthanized thereafter, and the kidneys were immediately excised, homogenized, and assayed for Ang II and AT 2 R expression.
Effects of Anesthesia on Intrarenal Ang II Levels
Rats (Nϭ6) on normal Na ϩ intake were implanted with renal cortical microdialysis catheters 48 hours before study. On the study day, a 60-minute collection of RI fluid was made, after which the animals were anesthetized for 4 hours, and RI fluid was again collected for 60 minutes during hour 4 of anesthesia. RI fluid was analyzed for Ang II.
Statistical Analysis
Data are presented as meanϮSE. ANOVA with a repeated-measures term was used to analyze for variation between the groups. A 2-tailed Student's t test was used to compare individual means between groups. A P value of Ͻ0.05 was considered statistically significant.
Results
Effects of Intrarenal D 1 -Like Receptor Activation on Na ؉ and Water Excretion
As demonstrated in Figure 1A , for RI fenoldopam-infused rats, U Na V increased from 0.31Ϯ0.05 mol/min in the control period to 0.59Ϯ0.10 mol/min at 1 hour (PϽ0.01) and continued to be elevated at 0.76Ϯ0.11 mol/min at 2 hours and 0.80Ϯ0.12 mol/min at 3 hours (both PϽ0.001). In contrast, U Na V values for the control vehicle-infused rats did not change significantly at any time. The ANOVA value comparing U Na V values for fenoldopam-versus vehicleinfused rats for the entire study was Fϭ12.1 (PϽ0.001). As shown in Figure 1B , urinary flow rate (V) for fenoldopaminfused rats increased from 0.003Ϯ0.0002 to 0.005Ϯ0.0003 L/min (PϽ0.01) at 1 hour. Thereafter, V continued to be increased significantly throughout the fenoldopam infusion. V also increased significantly in vehicle control rats, but the increase in V in fenoldopam-infused rats was significantly greater than with vehicle (PϽ0.01). The overall ANOVA value comparing V in fenoldopam-versus vehicle-infused animals was Fϭ4.0 (PϽ0.01). As shown in Figure 1C , Mean arterial blood pressure decreased slightly but significantly in both RI fenoldopam-and vehicle-infused groups during the 4 hours of the experiment. However, there was no significant difference in mean arterial blood pressure between vehicle and fenoldopam-infused rats (Fϭ1.9; P value not significant).
Effect of Intrarenal D 1 -Like Receptor Activation on Renal AT 2 R Protein Expression
As shown in Figure 2A , fenoldopam increased the expression of a 44-kDa band specific for the AT 2 R in enriched plasma membranes from renal cortical cells. As delineated in Figure  2B , fenoldopam infusion increased AT 2 R density by 69% (PϽ0.01) in enriched plasma membranes from renal cortical cells. In contrast, fenoldopam infusion did not increase total AT 2 R protein expression in renal cortical cells ( Figure 2C ). In enriched plasma membranes from RPT cells ( Figure 2D ), fenoldopam increased AT 2 R protein expression by 108% (PϽ0.01). In contrast, in Figure 2E , fenoldopam infusion did not increase total AT 2 R protein expression in RPT cells. Because the preparation of Nagamatsu et al 11 yields outer plasma membranes that may be contaminated with some internal cellular membranes, we isolated RPT outer apical membranes (AMs) and determined the effects of D 1 -like receptor activation on total cell and AM AT 2 R expression. Figure 3A shows a significant enrichment of RPT-specific marker villin in AMs isolated by the lectin pull-down assay compared with total RPT cell expression. Figure 3B demonstrates that fenoldopam did not significantly increase total RPT cell AT 2 R expression but increased RPT outer apical plasma membrane expression by 59% (PϽ0.01). Figure 4A demonstrates Western blot analysis of renal D 1 Rs in response to fenoldopam. Fenoldopam infusion increased renal cortical cell membrane D 1 R protein expression by 38% (PϽ0.01; Figure 4B ). In contrast, direct RI infusion of fenoldopam did not significantly increase total D 1 R protein expression ( Figure 4C ). 
Effects of D 1 -Like Receptor Activation on D 1 R Protein Expression
Effects of Pharmacological
4).
To determine whether the effects of fenoldopam were attributable to D 1 -like receptor activation, we also coinfused fenoldopam with and without SCH-23390 (SCH), a potent, highly selective D 1 -like receptor antagonist. Both fenoldopam-induced natriuresis and diuresis were abolished by intrarenal SCH. U Na V values for fenoldopam alone and fenoldopam plus SCH infusions, respectively, were 0.95Ϯ0.24 and 0.13Ϯ0.00 mol/min (PϽ0.01) at 1 hour, 1.07Ϯ0.21 and 0.20Ϯ0.01 mol/min (PϽ0.001) at 2 hours, and 0.82Ϯ0.14 and 0.20Ϯ0.01 mol/min (PϽ0.001) at 3 hours. Although the SCH-infused rats tended to have an antinatriuretic response during the control period before fenoldopam infusion, this difference did not reach statistical significance. Figure 5C , shows that none of the RI infusions of pharmacological agents caused any significant change in systemic arterial blood pressure at any time.
Effects of High Na
؉ Intake and Anesthesia on Intrarenal Ang II Levels and AT 2 
R Expression
To determine the intrarenal levels of endogenous AT 2 R agonist Ang II in these experiments, we performed studies on the effects of high Na ϩ intake and anesthesia on RI fluid and/or renal cortical Ang II levels. High Na ϩ diet did not alter RI Ang II levels from that on normal Na ϩ intake (high Na ϩ 0.01Ϯ0.006 versus low Na ϩ 0.01Ϯ0.004 fmol/min; Nϭ4; P value not significant). High Na ϩ diet increased renal tissue levels of Ang II insignificantly compared with values during normal Na ϩ intake (high Na ϩ 295Ϯ146 versus normal Na ϩ 220Ϯ75 pg per gram of kidney wet weight; Nϭ6; P value not significant). Anesthesia did not alter RI fluid levels of Ang II (anesthetized 0.05Ϯ0.01 versus nonanesthetized 0.05Ϯ0.01 fmol/min; Nϭ4; P value not significant). High Na ϩ intake induced a nonsignificant reduction in renal AT 2 R expression (high Na ϩ 84.2Ϯ10.6% versus 100% of normal Na ϩ control; Nϭ6; P value not significant).
Discussion
Intrarenal DA and Ang II are thought to act in paracrine fashion to modulate Na ϩ transport in renal tubules at D 1 -like receptors (D 1 and D 5 ) and AT 1 Rs, respectively. 1,16 DA and Ang II oppose each other in the regulation of Na ϩ transport in the RPT. DA, synthesized in and secreted from RPT cells, binds to D 1 -like receptors on the same or adjacent cells stimulating adenylyl cyclase activity and inhibiting NHE-3 activity, reducing Na ϩ reabsorption. 16, 17 When renal D 1 -like receptors are inhibited selectively by SCH, sustained antinatriuresis occurs. 5 Also, when D 1 R expression in rat kidney is reduced by local tissue administration of specific antisense oligodeoxynucleotides, a significant antinatriuresis occurs during both normal and high Na ϩ intake. 18 On the other hand, activation of AT 1 Rs, the major renal Ang II receptors in the kidney, inhibits adenylyl cyclase and increases Na ϩ transport in the RPT via NHE-3 and Na/KATPase, resulting in antinatriuresis. 19 Ang II, via AT 1 Rs, constricts both afferent and efferent arterioles and contracts the glomerular mesangium, resulting in decreased intrarenal blood flow and glomerular filtration rate. 19 Conversely, inhibition of AT 1 Rs increases renal blood flow, glomerular filtration rate, filtration fraction, and Na ϩ and water excretion. 19 Ang II binds to 2 major receptor subtypes, AT 1 and AT 2 . 20 Although the vast majority of actions of Ang II are mediated by AT 1 Rs, comparatively little is known regarding the renal actions of AT 2 Rs. 21, 22 The AT 2 R is expressed in the adult rat kidney at multiple sites, including proximal and distal tubules, glomeruli, renal blood vessels, juxtaglomerular cells, cortical and medullary collecting ducts, and cortical interstitial cells. 13, 23 The role of AT 2 Rs in renal hemodynamic function is largely unknown, although AT 2 Rs have been demonstrated to oppose AT 1 R-mediated vasoconstriction in the renal cortex. 24 A, RI infusion of PD and F abolished the F-induced increases in U Na V for all time periods in Na ϩ -loaded SpragueDawley rats. *PϽ0.01; ** PϽ0.001. RI infusion of SCH and F abolished the F-induced increases in U Na V for all time periods in Na ϩ -loaded Sprague-Dawley rats. e, vehicle-infused rats; f, fenoldopam-infused rats; _, F/PD-infused rats; 2, F/SCHinfused rats (Nϭ10 for each group). B, RI infusion of PD and F abolished the F-induced increase in V in Na ϩ -loaded SpragueDawley rats. *PϽ0.01; **PϽ0.001. Simultaneous RI infusion of SCH and F abolished the F-induced in increase in V in Na ϩ -loaded Sprague-Dawley rats. e, vehicle-infused rats; f, fenoldopam-infused rats; _, F/PD-infused rats; 2, F/SCHinfused rats (Nϭ10 for each group). C, None of the RI infusions of pharmacological agents caused a significant change in systemic arterial blood pressure in Na ϩ -loaded Sprague-Dawley rats. e, vehicle-infused rats; f, fenoldopam-infused rats; _, F/PD-infused rats; 2, F/SCH-infused rats (Nϭ10 for each group).
Several studies suggest that AT 2 R stimulation initiates a vasodilator cascade consisting of bradykinin, NO, and cGMP in direct opposition to Ang II-mediated vasoconstriction via AT 1 Rs. 8, [25] [26] [27] Available data suggest that AT 2 Rs have a functional role in BP regulation wherein systemic receptor activation induces vasodilation and hypotension in the presence of AT 1 R blockade in normal rats. 28, 29 In addition, the decrease in arterial pressure observed in normal rats infused with CGP-42112A, a selective AT 2 receptor agonist, was abolished in the presence of AT 2 R antagonist PD. 29 In contrast to its vascular actions, information regarding the actions of AT 2 Rs in renal tubule Na ϩ transport is scant. The only available cellular study suggests that RPT Na ϩ reabsorption is opposed by AT 2 Rs. 30 Most of the current knowledge comes from AT 2 R-null mice, which have exaggerated antinatriuretic responses to systemic Ang II infusion and are unable to generate a normal pressure-natriuresis response. 31, 32 However, because AT 1 Rs are chronically upregulated in AT 2 R-null mice, the interpretation of these studies is open to question. 33 The Nagamatsu et al 11 method used for plasma membrane isolation in these studies yields a 100 000g pellet that is enriched in outer plasma membranes but may be contaminated with intracellular membranes. Therefore, we specifically isolated apical plasma membranes of RPT cells using an LTA lectin pull-down assay. LTA binds to specific glycoproteins present only in proximal tubule brush border (apical) membranes. 35, 36 We demonstrate that AM fractions isolated with LTA were enriched with villin, validating the isolation of the outer brush border membrane fraction. Our results show that intrarenal administration of fenoldopam increased the quantity of AT 2 R protein in these AMs.
AT 2 R translocation is likely the result of intracellular receptor protein trafficking within RPT cells consisting of stimulation of cytoskeletal elements, such as microtubules and microfilaments. 37 These cellular "motors" cause vesicle/ organelle movement within the cell, a relationship necessary to maintain proper distribution of membrane proteins. 38 Observations from RPT cells have demonstrated that administration of the DA precursor L-3,4-dihydroxyphenylalanine or D 1 -like receptor agonist fenoldopam induces translocation of D 1 Rs from the intracellular compartment to the plasma membrane and that subcellular receptor translocation was prevented by nocodazole, a microtubulin network disruptor. 39, 40 We speculate that D 1 -like receptor stimulation with fenoldopam, similar to its action on D 1 R recruitment, causes microtubules to move both D 1 R and AT 2 R proteins to the plasma membrane. Under this scenario, D 1 -like receptor recruitment of AT 2 Rs to the plasma membrane would require an intact microtubulin network. According to our hypothesis, AT 2 R activation by D 1 -like receptor stimulation would lead to inhibition of the NHE-3 and Na/K ATPase activities, thereby reducing Na ϩ reabsorption in RPT cells, as hypothesized in Figure 6 .
A possible limitation of the present study is that the changes in Na ϩ and water excretion observed with fenoldopam infusion may have been attributable, at least in part, to downregulation of AT 1 Rs. However, AT 1 R downregulation is unlikely to have occurred within a time span of fenoldopam infusion as short as 3 hours in these experiments. Furthermore, the abolition of fenoldopam-induced natriuresis with PD, a specific AT 2 R antagonist, indicates the primary role of AT 2 Rs in the regulation of Na ϩ excretion. Whether or not fenoldopam-induced natriuresis requires Ang II binding and activation of AT 2 Rs in the traditional manner has not yet been tested. However, we were able to demonstrate that intrarenal Ang II levels were not suppressed by either high Na ϩ intake or anesthesia. Therefore, Ang II would be available for binding to AT 2 Rs under these experimental conditions.
Perspectives
This study elucidates the interaction between the renal dopaminergic system and renin-angiotensin system, affording a better understanding of renal Na ϩ and water handling. Our results demonstrate that D 1 -like receptors not only oppose the actions of Ang II via AT 1 Rs but also require AT 2 Rs to reduce renal Na ϩ reabsorption. These findings have clinical implications in cardiovascular medicine and hypertension where the focus has been predominantly on AT 1 R blockade and inhibition of the entire renin-angiotensin system. The present study encourages the clinical development of renal AT 2 R and/or D 1 -like receptor agonists to take advantage of their probable beneficial effects on renal Na ϩ and water excretion.
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